38
Participants
Start Date
May 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
January 31, 2014
cediranib maleate
gefitinib
Placebo
University College Hospital, London
Queen Elizabeth Hospital, Birmingham
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital, Cambridge
Royal Surrey County Hospital, Guildford
Castle Hill Hospital, Hull
Charing Cross Hospital, London
The Christie NHS Foundation Trust, Manchester
Southampton General Hospital, Southampton
Royal Marsden Hospital, Sutton
Collaborators (1)
AstraZeneca
INDUSTRY
University College, London
OTHER